Michel Rider describes how GSK has future-proofed their clinical strategy to accelerate research and development, along with Leonie Christianson from GSK discusses how CDMS is giving them a modern foundation to accelerate their future goals.
Read our latest blog on how GSK Puts Data First in New Clinical Agility Benchmarks.